Lau-Min et al. (2024). Association between oral targeted cancer drug net health benefit, uptake, and spending.

Association between oral targeted cancer drug net health benefit, uptake, and spending.

Lau-Min, KS., Wu, X., Rochester, S., Bekelman, JE., Kanter, GP., Getz, KD.

JNCI: Journal of the National Cancer Institute, Volume 116, Issue 9, September 2024, Pages 1479–1486, https://doi.org/10.1093/jnci/djae110